The Daily Courier

Could vaccine cause trouble for transplant recipient?

- KEITH To Your Good Health Readers may email questions to ToYourGood­Health@med.cornell.edu

DEAR DR. ROACH: I am an organ transplant recipient who has received both COVID vaccinatio­ns and both boosters. I did this because numerous medical profession­als recommende­d them for immunosupp­ressed patients, but I am wondering if I did the right thing.

I take immunosupp­ressants to keep my body from producing antibodies that would attack my donor kidney. Unfortunat­ely, immunosupp­ressants effect my entire immune system, making me highly vulnerable to viruses, bacteria, etc. I am afraid that by stimulatin­g my body to produce an antibody to the COVID virus, it will boost my immune system to produce antibodies that might attack my new kidney. Am I in a Catch-22 situation?

— G.K. ANSWER: I understand why you are concerned, but the COVID vaccine stimulates your immune system to make only the antibodies directed against the COVID spike protein. These antibodies are precise and do not react to the donor kidney or your own body. Many people in your situation have gotten the vaccines and have not had any rejection. You did the right thing.

People with autoimmune disease also ask a similar question: Will the increase in immune system activity cause my autoimmune disease to flare? This has proven to be more of a theoretica­l concern than a real one, with no more flares after vaccinatio­n reported than would be expected without one, in people with multiple sclerosis and other autoimmune diseases.

Because of the immunosupp­ressive medicines necessary to prevent rejection of a transplant­ed organ (your kidney), organ recipients are indeed at higher risk of infection, so the COVID vaccine (as well as vaccines against other infections) are particular­ly important.

Some people who are unable to make antibodies because of an immune system disease or medication that suppresses this ability are at high risk. Those patients may want to consider tixagevima­b and cilgavimab (Evusheld). This provides approximat­ely six months of protection against COVID infection, reducing symptomati­c infection rates by almost 80%. Many people who would benefit from this don’t know about it.

If you do get COVID despite preventive medication, you should get treatment.

DEAR DR. ROACH: I’ve heard that women could raise another considerat­ion about statins: that studies on their efficacy were done on men only, and that nothing has been establishe­d on the way they do or do not work on women. Is that true?

— C.D.C. ANSWER: Many of the initial studies were indeed done on men only, and even in those done on men and women, the number of women in the individual studies was not enough to prove a benefit. Since then, studies have confirmed that women with coronary disease benefit from statin drugs. In women without known blockages in the arteries, combining the results from many trials has shown that women achieve about the same benefit as men do.

However, since women have a lower risk for heart disease when compared to men of the same age, there is less of an absolute benefit for women. To complicate matters further, women who could benefit from a statin are treated with statins less often than men are, and are consequent­ly at a higher risk than they should be.

Women may be at higher risk for muscle aches then men, and statins must not be taken by pregnant women. As always, lifestyle changes, especially with diet and exercise, are the first line in preventing heart disease.

 ?? ??

Newspapers in English

Newspapers from Canada